(MENAFN- PR Newswire) BALTIMORE, Feb. 12, 2025 /PRNewswire/ -- Today, Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, which provides additional clinical validation of …

FOR IMMEDIATE RELEASE By studying biomarkers known to be involved in gastrointestinal cancers, researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a biomarker algorithm that, when …

Epigenetic test for risk-stratification impacts gastroenterologists' decision making and improves confidence when caring for patients with Barrett's esophagus. BALTIMORE, Oct. 28, 2024 /PRNewswire/ -- Previse, a gastrointestinal health …

Funder: Dr. Aoki is supported by theAPAGE/JGH Foundation Clinician-ScientistTraining Fellowship. Dr. Bulamu is supported bya Cancer Council South Australia Beat CancerEarly Career Research Fellowship From: Flinders University New research is exploring …

This transcript has been edited for clarity.  Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School and Old Dominion University in Norfolk, Virginia.  The American College of …

TOPLINE: A new epigenetic assay is able to stratify patients with Barrett's esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma within 5 years, aiding in clinical decision-making. …

April serves as Esophageal Cancer Awareness Month, and has since 2009, according to the Esophageal Cancer Action Network. Esophageal cancer forms in the lining of the esophagus, and according to the National Cancer Institute, approximately 22,370 people …

Esophageal cancer is not one of the most publicized cancers or targeted in awareness campaigns. However, it is a type of cancer whose causes are now well identified, often linked to certain behaviors or lifestyles, which makes it possible to prevent its …

The American Gastroenterological Association (AGA) has released updated evidence-based recommendations on the endoscopic eradication therapy (EET) of Barrett's esophagus (BE) and related neoplasms. Published in Gastroenterology, the clinical practice …

Pivotal Multi-Center Study Highlights AI Platform's Powerful Diagnostic Impact and Ability to Enhance Patient Outcomes SUFFERN, N.Y., May 17, 2024 /PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and …